Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Recent News

December 18, 2014
Pacific Biosciences Appoints Kathy Ordonez to Board of Directors

MENLO PARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that it has appointed...


November 10, 2014
Researchers Use PacBio Sequencing to Create More Complete Human Genome Reference and Discover New Forms of Structural Variation; Paper Published in Nature

MENLO PARK, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, announced that a paper published onli...


Events & Presentations

Jan 12, 2015
33rd Annual J.P. Morgan Healthcare Conference

Stock Quote

NASDAQ (GM) : PACB
Price
$7.50
Last Trade
4:00 PM ET
Dec 19, 2014
Change
$+0.23
Change (%)
+3.164%
Volume
744,000
52 Week High
8.20
52 Week Low
3.87
Day High
7.50
Day Low
7.06

Investor
Contacts

Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450
ir@pacificbiosciences.com

Supernav grey background

Supernav grey background

Super Navigation block